{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T20:19:49Z","timestamp":1767644389664,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04507-1","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:21:17Z","timestamp":1767633677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparable epicardial adipose tissue burden in prediabetes with high cardiometabolic risk and early type 2 diabetes: A need for timely targeted therapies"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6656-8569","authenticated-orcid":false,"given":"Mainak","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhajit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debrupa","family":"Deb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debabrata","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debasree","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debika","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"4507_CR1","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2337\/dc22-2376","volume":"46","author":"MR Rooney","year":"2023","unstructured":"M.R. Rooney, M. Fang, K. Ogurtsova, B. Ozkan, J.B. Echouffo-Tcheugui, E.J. Boyko et al., Global prevalence of prediabetes. Diabetes Care. 46, 1388\u20131394 (2023). https:\/\/doi.org\/10.2337\/dc22-2376","journal-title":"Diabetes Care"},{"key":"4507_CR2","doi-asserted-by":"publisher","unstructured":"X. Cai, Y. Zhang, M. Li, J.H. Wu, L. Mai, J. Li et al., Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. m2297 (2020). https:\/\/doi.org\/10.1136\/bmj.m2297","DOI":"10.1136\/bmj.m2297"},{"key":"4507_CR3","doi-asserted-by":"publisher","unstructured":"R.A. DeFronzo, M. Abdul-Ghani, Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am. J. Cardiol. 108 (2011). https:\/\/doi.org\/10.1016\/j.amjcard.2011.03.013. :3B-24B","DOI":"10.1016\/j.amjcard.2011.03.013"},{"key":"4507_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2011.08.080","volume":"59","author":"SM Grundy","year":"2012","unstructured":"S.M. Grundy, M. Pre-Diabetes, Syndrome, C. Risk, J. Am. Coll. Cardiol. 59, 635\u2013643 (2012). https:\/\/doi.org\/10.1016\/j.jacc.2011.08.080","journal-title":"J. Am. Coll. Cardiol."},{"key":"4507_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","volume":"56","author":"S Mottillo","year":"2010","unstructured":"S. Mottillo, K.B. Filion, J. Genest, L. Joseph, L. Pilote, P. Poirier et al., The metabolic syndrome and cardiovascular risk. J. Am. Coll. Cardiol. 56, 1113\u20131132 (2010). https:\/\/doi.org\/10.1016\/j.jacc.2010.05.034","journal-title":"J. Am. Coll. Cardiol."},{"key":"4507_CR6","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.2337\/dc24-S003","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee, N.A. ElSayed, G. Aleppo, R.R. Bannuru, D. Bruemmer, B.S. Collins et al., Prevention or delay of diabetes and associated comorbidities: Standards of care in diabetes\u20142024. Diabetes Care. 47, S43\u201351 (2024). 3https:\/\/doi.org\/10.2337\/dc24-S003","journal-title":"Diabetes Care"},{"key":"4507_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"F. Cosentino, P.J. Grant, V. Aboyans, C.J. Bailey, A. Ceriello, V. Delgado et al., 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 41, 255\u2013323 (2020). https:\/\/doi.org\/10.1093\/eurheartj\/ehz486","journal-title":"Eur. Heart J."},{"key":"4507_CR8","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"N. Marx, M. Federici, K. Sch\u00fctt, D. M\u00fcller-Wieland, R.A. Ajjan, M.J. Antunes et al., 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur. Heart J. 44, 4043\u20134140 (2023). https:\/\/doi.org\/10.1093\/eurheartj\/ehad192","journal-title":"Eur. Heart J."},{"key":"4507_CR9","doi-asserted-by":"publisher","first-page":"109980","DOI":"10.1016\/j.diabres.2022.109980","volume":"190","author":"JS Neves","year":"2022","unstructured":"J.S. Neves, C. Newman, J.A. Bostrom, M. Buysschaert, J.D. Newman, J.L. Medina et al., Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes. Diabetes Res. Clin. Pract. 190, 109980 (2022). https:\/\/doi.org\/10.1016\/j.diabres.2022.109980","journal-title":"Diabetes Res. Clin. Pract."},{"key":"4507_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ijo.2010.135","volume":"35","author":"A Misra","year":"2011","unstructured":"A. Misra, L. Khurana, Obesity-related non-communicable diseases: South Asians vs white Caucasians. Int. J. Obes. 35, 167\u2013187 (2011). https:\/\/doi.org\/10.1038\/ijo.2010.135","journal-title":"Int. J. Obes."},{"key":"4507_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"G. Iacobellis, Epicardial adipose tissue in contemporary cardiology. Nat. Rev. Cardiol. 19, 593\u2013606 (2022). https:\/\/doi.org\/10.1038\/s41569-022-00679-9","journal-title":"Nat. Rev. Cardiol."},{"key":"4507_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41598-023-28679-w","volume":"13","author":"D Molnar","year":"2023","unstructured":"D. Molnar, E. Bj\u00f6rnson, M. Larsson, M. Adiels, A. Gummesson, F. B\u00e4ckhed et al., Pre-diabetes is associated with Attenuation rather than volume of epicardial adipose tissue on computed tomography. Sci. Rep. 13, 1623 (2023). https:\/\/doi.org\/10.1038\/s41598-023-28679-w","journal-title":"Sci. Rep."},{"key":"4507_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2261-13-98","volume":"13","author":"F-S Yang","year":"2013","unstructured":"F.-S. Yang, C.-H. Yun, T.-H. Wu, Y.-C. Hsieh, H.G. Bezerra, C.-C. Liu et al., High pericardial and peri-aortic adipose tissue burden in pre-diabetic and diabetic subjects. BMC Cardiovasc. Disord. 13, 98 (2013). https:\/\/doi.org\/10.1186\/1471-2261-13-98","journal-title":"BMC Cardiovasc. Disord"},{"key":"4507_CR14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00592-019-01348-z","volume":"56","author":"S Wang","year":"2019","unstructured":"S. Wang, Z. Wang, C. Chen, L. Zhu, S. Gu, L. Qin et al., Contribution of epicardial and abdominopelvic visceral adipose tissues in Chinese adults with impaired glucose regulation and diabetes. Acta Diabetol. 56, 1061\u20131071 (2019). https:\/\/doi.org\/10.1007\/s00592-019-01348-z","journal-title":"Acta Diabetol."},{"key":"4507_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-publhealth-090419-102644","volume":"42","author":"JB Echouffo-Tcheugui","year":"2021","unstructured":"J.B. Echouffo-Tcheugui, E. Selvin, Prediabetes and what it means: the epidemiological evidence. Annu. Rev. Public. Health. 42, 59\u201377 (2021). https:\/\/doi.org\/10.1146\/annurev-publhealth-090419-102644","journal-title":"Annu. Rev. Public. Health"},{"key":"4507_CR16","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"NA ElSayed","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee, N.A. ElSayed, R.G. McCoy, G. Aleppo, K. Balapattabi, E.A. Beverly et al., 2. Diagnosis and classification of diabetes: standards of care in Diabetes\u20142025. Diabetes Care. 48, S27\u201349 (2025). https:\/\/doi.org\/10.2337\/dc25-S002","journal-title":"Diabetes Care"},{"key":"4507_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","volume":"10","author":"S Abbara","year":"2016","unstructured":"S. Abbara, P. Blanke, C.D. Maroules, M. Cheezum, A.D. Choi, B.K. Han et al., SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of cardiovascular computed tomography guidelines committee. J. Cardiovasc. Comput. Tomogr. 10, 435\u2013449 (2016). https:\/\/doi.org\/10.1016\/j.jcct.2016.10.002","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"4507_CR18","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1109\/TMI.2018.2804799","volume":"37","author":"F Commandeur","year":"2018","unstructured":"F. Commandeur, M. Goeller, J. Betancur, S. Cadet, M. Doris, X. Chen et al., Deep learning for quantification of epicardial and thoracic adipose tissue from Non-Contrast CT. IEEE Trans. Med. Imaging. 37, 1835\u20131846 (2018). https:\/\/doi.org\/10.1109\/TMI.2018.2804799","journal-title":"IEEE Trans. Med. Imaging"},{"key":"4507_CR19","doi-asserted-by":"publisher","unstructured":"Division of Radiology, University of, P. Parma, G. Italy, Milanese, Department of Medicine and Surgery, University of Parma, Parma, Italy, M. Silva et al., Division of Radiology, University of Parma, Parma, Italy, Department of Medicine and Surgery, University of Parma, Parma, Italy, Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: from the ALTER-BIO (Alternative Cardiovascular Bio-Imaging markers) registry. Diagn Interv Radiol. 2019;25:35\u201341. https:\/\/doi.org\/10.5152\/dir.2018.18037","DOI":"10.5152\/dir.2018.18037"},{"key":"4507_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"S.P. Hozo, B. Djulbegovic, I. Hozo, Estimating the mean and variance from the median, range, and the size of a sample. BMC Med. Res. Methodol. 5, 13 (2005). https:\/\/doi.org\/10.1186\/1471-2288-5-13","journal-title":"BMC Med. Res. Methodol."},{"key":"4507_CR21","volume-title":"Fundamentals of Biostatistics","author":"BA Rosner","year":"2006","unstructured":"B.A. Rosner, Fundamentals of Biostatistics, vol. 6 (Thomson-Brooks\/Cole, Belmont, CA, 2006)"},{"key":"4507_CR22","doi-asserted-by":"publisher","unstructured":"Y. Huang, X. Cai, W. Mai, M. Li, Y. Hu, Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. i5953 (2016). https:\/\/doi.org\/10.1136\/bmj.i5953","DOI":"10.1136\/bmj.i5953"},{"key":"4507_CR23","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2337\/dc06-0242","volume":"29","author":"LS Phillips","year":"2006","unstructured":"L.S. Phillips, W.S. Weintraub, D.C. Ziemer, P. Kolm, J.K. Foster, V. Vaccarino et al., All Pre-Diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110\u00a0mg\/dl. Diabetes Care. 29, 1405\u20131407 (2006). https:\/\/doi.org\/10.2337\/dc06-0242","journal-title":"Diabetes Care"},{"issue":"12","key":"4507_CR24","doi-asserted-by":"publisher","first-page":"e010966","DOI":"10.1161\/CIRCHEARTFAILURE.123.010966","volume":"16","author":"M. Banerjee","year":"2023","unstructured":"M. Banerjee, Epicardial Fat Paradox and Differential Effects of GLP-1 Receptor Agonists across Heart Failure Phenotypes. Circ. Heart Fail. 16(12), e010966 (2023) https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.123.010966","journal-title":"Circ. Heart Fail."},{"key":"4507_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.atherosclerosis.2019.01.033","volume":"284","author":"Z Liu","year":"2019","unstructured":"Z. Liu, S. Wang, Y. Wang, N. Zhou, J. Shu, C. Stamm et al., Association of epicardial adipose tissue Attenuation with coronary atherosclerosis in patients with a high risk of coronary artery disease. Atherosclerosis. 284, 230\u2013236 (2019). https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.033","journal-title":"Atherosclerosis"},{"key":"4507_CR26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/2047487316679524","volume":"24","author":"BT Franssens","year":"2017","unstructured":"B.T. Franssens, H.M. Nathoe, T. Leiner, Van Der Y. Graaf, F.L. Visseren, Relation between cardiovascular disease risk factors and epicardial adipose tissue density on cardiac computed tomography in patients at high risk of cardiovascular events. Eur. J. Prev. Cardiolog. 24, 660\u2013670 (2017). https:\/\/doi.org\/10.1177\/2047487316679524","journal-title":"Eur. J. Prev. Cardiolog"},{"key":"4507_CR27","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.2337\/dc23-0696","volume":"46","author":"T Sathish","year":"2023","unstructured":"T. Sathish, K. Khunti, K.M.V. Narayan, V. Mohan, M.J. Davies, T. Yates et al., Effect of conventional lifestyle interventions on type 2 diabetes incidence by Glucose-Defined prediabetes phenotype: an individual participant data Meta-analysis of randomized controlled trials. Diabetes Care. 46, 1903\u20131907 (2023). https:\/\/doi.org\/10.2337\/dc23-0696","journal-title":"Diabetes Care"},{"key":"4507_CR28","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1093\/eurheartj\/ehae533","volume":"45","author":"N Marx","year":"2024","unstructured":"N. Marx, L. Ryd\u00e9n, M. Federici, K. Marx-Sch\u00fctt, M. Verket, D. M\u00fcller-Wieland et al., Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction. Eur. Heart J. 45, 5117\u20135126 (2024). https:\/\/doi.org\/10.1093\/eurheartj\/ehae533","journal-title":"Eur. Heart J."},{"key":"4507_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/eurjpc\/zwad050","volume":"30","author":"AE Malavazos","year":"2023","unstructured":"A.E. Malavazos, G. Iacobellis, E. Dozio, S. Basilico, Di A. Vincenzo, C. Dubini et al., Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies. Eur. J. Prev. Cardiol. 30, 680\u2013693 (2023). https:\/\/doi.org\/10.1093\/eurjpc\/zwad050","journal-title":"Eur. J. Prev. Cardiol."},{"key":"4507_CR30","doi-asserted-by":"publisher","first-page":"107424842211463","DOI":"10.1177\/10742484221146371","volume":"27","author":"EM Muzurovi\u0107","year":"2022","unstructured":"E.M. Muzurovi\u0107, \u0160. Vol\u010dan\u0161ek, K.Z. Tom\u0161i\u0107, A. Jane\u017e, D.P. Mikhailidis, M. Rizzo et al., Glucagon-Like Peptide-1 receptor agonists and dual Glucose-Dependent insulinotropic Polypeptide\/Glucagon-Like Peptide-1 receptor agonists in the treatment of Obesity\/Metabolic Syndrome, Prediabetes\/Diabetes and Non-Alcoholic fatty liver Disease\u2014Current evidence. J. Cardiovasc. Pharmacol. Ther. 27, 107424842211463 (2022). https:\/\/doi.org\/10.1177\/10742484221146371","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"4507_CR31","doi-asserted-by":"publisher","first-page":"102562","DOI":"10.1016\/j.dsx.2022.102562","volume":"16","author":"G Berg","year":"2022","unstructured":"G. Berg, M. Barchuk, M. Lobo, J.P. Nogueira, Effect of glucagon-like peptide-1 (GLP-1) analogues on epicardial adipose tissue: A meta-analysis. Diabetes Metabolic Syndrome: Clin. Res. Reviews. 16, 102562 (2022). https:\/\/doi.org\/10.1016\/j.dsx.2022.102562","journal-title":"Diabetes Metabolic Syndrome: Clin. Res. Reviews"},{"key":"4507_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/dom.16107","volume":"27","author":"Y Bao","year":"2025","unstructured":"Y. Bao, Y. Hu, M. Shi, Z. Zhao, SGLT2 inhibitors reduce epicardial adipose tissue more than GLP -1 agonists or exercise interventions in patients with type 2 diabetes mellitus and\/or obesity: A systematic review and network meta\u2010analysis. Diabetes Obes. Metabolism. 27, 1096\u20131112 (2025). https:\/\/doi.org\/10.1111\/dom.16107","journal-title":"Diabetes Obes. Metabolism"},{"key":"4507_CR33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"A.M. Lincoff, K. Brown-Frandsen, H.M. Colhoun, J. Deanfield, S.S. Emerson, S. Esbjerg et al., Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl. J. Med. 389, 2221\u20132232 (2023). https:\/\/doi.org\/10.1056\/NEJMoa2307563","journal-title":"N Engl. J. Med."},{"key":"4507_CR34","doi-asserted-by":"publisher","first-page":"14243","DOI":"10.3390\/ijms241814243","volume":"24","author":"J Matthews","year":"2023","unstructured":"J. Matthews, L. Herat, M.P. Schlaich, V. Matthews, The impact of SGLT2 inhibitors in the heart and kidneys regardless of diabetes status. IJMS. 24, 14243 (2023). https:\/\/doi.org\/10.3390\/ijms241814243","journal-title":"IJMS"},{"key":"4507_CR35","doi-asserted-by":"publisher","unstructured":"M.E. Turan Erdogan, M. Durakoglugil, S.A. \u00c7etin, H. Kocaman, Y. Duman, \u00c7i\u00e7ek et al., Epicardial adipose tissue predicts carotid Intima-Media thickness independently of body mass index and waist circumference. Acta Cardiol. Sinica 2019;35. https:\/\/doi.org\/10.6515\/ACS.201901_35(1).20180628A","DOI":"10.6515\/ACS.201901_35(1).20180628A"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04507-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04507-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04507-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:21:20Z","timestamp":1767633680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04507-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4507"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04507-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective analysis was approved by institutional ethics committee. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"29"}}